Evidence map›Paper›PMID 26787692›Full record

ArticleAntimicrobial agents and chemotherapy2016

The Nonartemisinin Sesquiterpene Lactones Parthenin and Parthenolide Block Plasmodium falciparum Sexual Stage Transmission.

Jared N Balaich, Derrick K Mathias, Baldwyn Torto, Bryan T Jackson, Dingyin Tao, Babak Ebrahimi, Brian B Tarimo, Xavier Cheseto, Woodbridge A Foster, Rhoel R Dinglasan

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jared N BalaichW. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health and Malaria Research Institute, Baltimore, Maryland, USA.
Derrick K MathiasW. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health and Malaria Research Institute, Baltimore, Maryland, USA.
Baldwyn TortoThe International Centre of Insect Physiology and Ecology, Nairobi, Kenya.
Bryan T JacksonDepartment of Evolution, Ecology, and Organismal Biology, The Ohio State University, Columbus, Ohio, USA.
Dingyin TaoW. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health and Malaria Research Institute, Baltimore, Maryland, USA.
Babak EbrahimiDepartment of Entomology, The Ohio State University, Columbus, Ohio, USA.
Brian B TarimoW. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health and Malaria Research Institute, Baltimore, Maryland, USA Ifakara Health Institute, Dar es Salaam, Tanzania Nelson Mandela African Institute for Science and Technology, Arusha, Tanzania.
Xavier ChesetoThe International Centre of Insect Physiology and Ecology, Nairobi, Kenya.
Woodbridge A FosterDepartment of Evolution, Ecology, and Organismal Biology, The Ohio State University, Columbus, Ohio, USA.
Rhoel R DinglasanW. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health and Malaria Research Institute, Baltimore, Maryland, USA rdinglasan@jhu.edu.

Funding

Small molecule protein-glycan inhib. as malaria transmission-blocking therapueticR01AI082587 · NIAID · JOHNS HOPKINS UNIVERSITY · PI DINGLASAN, RHOEL DAVID RAMOS · 2009 to 2013
$1.9M
NIAID NIH HHS 5R01AI082587PHS HHS R01A1077722
6 · The paper itself

Abstract

Parthenin and parthenolide are natural products that are closely related in structure to artemisinin, which is also a sesquiterpene lactone (SQL) and one of the most important antimalarial drugs available. Parthenin, like artemisinin, has an effect onPlasmodiumblood stage development. We extended the evaluation of parthenin as a potential therapeutic for the transmissible stages ofPlasmodium falciparumas it transitions between human and mosquito, with the aim of gaining potential mechanistic insight into the inhibitory activity of this compound. We posited that if parthenin targets different biological pathways in the parasite, this in turn could pave the way for the development of druggable compounds that could prevent the spread of artemisinin-resistant parasites. We examined parthenin's effect on male gamete activation and the ookinete-to-oocyst transition in the mosquito as well as on stage V gametocytes that are present in peripheral blood. Parthenin arrested parasite development for each of the stages tested. The broad inhibitory properties of parthenin on the evaluated parasite stages may suggest different mechanisms of action between parthenin and artemisinin. Parthenin's cytotoxicity notwithstanding, its demonstrated activity in this study suggests that structurally related SQLs with a better safety profile deserve further exploration. We used our battery of assays to test parthenolide, which has a more compelling safety profile. Parthenolide demonstrated activity nearly identical to that of parthenin againstP. falciparum, highlighting its potential as a possible transmission-blocking drug scaffold. We discuss the context of the evidence with respect to the next steps toward expanding the current antimalarial arsenal.

Indexed as

AnimalsAnophelesAntimalarialsArtemisininsDrug ResistanceErythrocytesFemaleGene ExpressionGenes, ReporterGreen Fluorescent ProteinsHumansInhibitory Concentration 50Life Cycle StagesMalariaMaleMiceAntimalarialsArtemisininsGreen Fluorescent ProteinspartheninparthenolideSesquiterpenes

Identifiers

PMID26787692
PMCPMC4808191

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.